Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.47 USD | +1.05% | -1.59% | -22.18% |
Sales 2024 * | 15.35M 19.17M 1.53B | Sales 2025 * | 103M 129M 10.33B | Capitalization | 1.01B 1.26B 101B |
---|---|---|---|---|---|
Net income 2024 * | -83M -104M -8.3B | Net income 2025 * | -38M -47.46M -3.8B | EV / Sales 2024 * | 53.6 x |
Net cash position 2024 * | 184M 230M 18.39B | Net cash position 2025 * | 146M 183M 14.64B | EV / Sales 2025 * | 8.32 x |
P/E ratio 2024 * |
-24.1
x | P/E ratio 2025 * |
-81.4
x | Employees | 79 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 75.42% |
Latest transcript on Verona Pharma plc
1 day | +1.05% | ||
1 week | -1.59% | ||
Current month | -3.85% | ||
1 month | -6.24% | ||
3 months | -13.53% | ||
6 months | +16.84% | ||
Current year | -22.18% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 31/01/20 | |
Mark Hahn
DFI | Director of Finance/CFO | 61 | 29/02/20 |
Kavita Aggarwal
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mahendra Shah
BRD | Director/Board Member | 79 | 16/06/16 |
Vikas Sinha
BRD | Director/Board Member | 60 | 11/09/16 |
David Ebsworth
CHM | Chairman | 69 | 30/11/14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.09% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 15.47 | +1.05% | 260,511 |
25/04/24 | 15.31 | +0.46% | 499,479 |
24/04/24 | 15.24 | -2.25% | 316,407 |
23/04/24 | 15.59 | -0.83% | 359,330 |
22/04/24 | 15.72 | 0.00% | 459,032 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.18% | 1.25B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- VRNA Stock